American Cancer Society Announces New Diversity In Cancer Research Program 0 - Latest News

American Cancer Society announces new diversity in cancer research program

Atlanta— The American Cancer Society announced ... Family Diversity in Research Internship” name. In addition, an advisory committee has been formed to focus on the implementation of the internship ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

GO2 Foundation Leads Study to Improve Participation of Black Communities in Lung Cancer Clinical Trials

SAN CARLOS, Calif. and WASHINGTON, March 4, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) announced its leadership in the launch of an important multi-institutional study to det ... read more

Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its operational and financial results for ... read more

Patrick Delaney Named New Executive Director of NCCN Foundation

The National Comprehensive Cancer Network® ( NCCN ®) today announced the appointment of Patrick Delaney as incoming Executive Director for the NCCN Foundation ®. Delaney has previously held leadership ... read more

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results

Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 7 leading US clinical ... read more

Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial ...

Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance, ... read more

Jefferies' Clients, Employees and Shareholders "Do Good" by Donating $8,300,000 to 129 Charities

Jefferies announced today a total donation of approximately $8.3 million that will result in 129 charities each receiving $65,000. Jefferies’ firmwide global charity trading day effort will send much ... read more

Compugen Announces Data Update from COM701 Phase 1 Clinical Trial

PRNewswire/ -- (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, reported today updated data from its Phase ... read more

Actinium Announces Appointment of Mark Kubik, MBA as Chief Business Officer

PRNewswire/ -- (NYSE AMERICAN: ATNM) ("Actinium") today announced the appointment of Mark Kubik, MBA to the position of Chief Business Officer (CBO). read more

Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated ... read more

Carrollton clears first hurdle in receiving $500,000 grant for Midtown Water Park

The DNR issued $8.4 million in outdoor recreation grant funds Thursday through its Land and Water Conservation Fund program ... construct a new park entrance and demolish a building within ... read more

Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting

(NASDAQ: CLVS) today announced Rubraca data being presented at the American Society for Clinical Oncology (ASCO) Genitourinary Cancers Virtual Symposium 2021. These include data from the Phase 1b RAMP ... read more